. | Univariable model . | Multivariable model . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
Morphology | ||||||
Right isomerism | 0.35 | 0.39–5.09 | 0.59 | |||
Common AVV | 0.46 | 0.17–1.24 | 0.13 | |||
Dextorcardia | 0.49 | 0.17–1.42 | 0.19 | |||
Dominant right ventricle | 1.41 | 0.41–5.12 | 0.59 | |||
Pulmonary flow | ||||||
Restrictive | 2.81 | 0.90–8.74 | 0.08 | 3.23 | 1.02–10.2 | 0.05 |
Balanced | 0.03 | 0.01–6.19 | 0.20 | |||
Excessive | 0.89 | 0.29–2.75 | 0.83 | |||
Pulmonary venous return | ||||||
TAPVC | 1.55 | 0.56–4.26 | 0.40 | |||
Extracardiac TAPVC | 0.56 | 0.36–3.05 | 0.92 | |||
Obstructive TAPVC | 0.50 | 0.14–2.60 | 0.51 | |||
Systemic venous return | ||||||
Azygos continuation | 1.18 | 0.41–3.41 | 0.75 | |||
Bilateral SVC | 0.86 | 0.31–2.35 | 0.76 | |||
AVV regurgitation | ||||||
Greater than mild AVVR | 3.06 | 1.11–8.48 | 0.03 | 3.57 | 1.27–10.0 | 0.02 |
. | Univariable model . | Multivariable model . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
Morphology | ||||||
Right isomerism | 0.35 | 0.39–5.09 | 0.59 | |||
Common AVV | 0.46 | 0.17–1.24 | 0.13 | |||
Dextorcardia | 0.49 | 0.17–1.42 | 0.19 | |||
Dominant right ventricle | 1.41 | 0.41–5.12 | 0.59 | |||
Pulmonary flow | ||||||
Restrictive | 2.81 | 0.90–8.74 | 0.08 | 3.23 | 1.02–10.2 | 0.05 |
Balanced | 0.03 | 0.01–6.19 | 0.20 | |||
Excessive | 0.89 | 0.29–2.75 | 0.83 | |||
Pulmonary venous return | ||||||
TAPVC | 1.55 | 0.56–4.26 | 0.40 | |||
Extracardiac TAPVC | 0.56 | 0.36–3.05 | 0.92 | |||
Obstructive TAPVC | 0.50 | 0.14–2.60 | 0.51 | |||
Systemic venous return | ||||||
Azygos continuation | 1.18 | 0.41–3.41 | 0.75 | |||
Bilateral SVC | 0.86 | 0.31–2.35 | 0.76 | |||
AVV regurgitation | ||||||
Greater than mild AVVR | 3.06 | 1.11–8.48 | 0.03 | 3.57 | 1.27–10.0 | 0.02 |
AVV: atrioventricular valve; AVVR: atrioventricular valve regurgitation; HR: hazard ratio; SVC: superior vena cava; TAPVC: total anomalous pulmonary venous connection.
. | Univariable model . | Multivariable model . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
Morphology | ||||||
Right isomerism | 0.35 | 0.39–5.09 | 0.59 | |||
Common AVV | 0.46 | 0.17–1.24 | 0.13 | |||
Dextorcardia | 0.49 | 0.17–1.42 | 0.19 | |||
Dominant right ventricle | 1.41 | 0.41–5.12 | 0.59 | |||
Pulmonary flow | ||||||
Restrictive | 2.81 | 0.90–8.74 | 0.08 | 3.23 | 1.02–10.2 | 0.05 |
Balanced | 0.03 | 0.01–6.19 | 0.20 | |||
Excessive | 0.89 | 0.29–2.75 | 0.83 | |||
Pulmonary venous return | ||||||
TAPVC | 1.55 | 0.56–4.26 | 0.40 | |||
Extracardiac TAPVC | 0.56 | 0.36–3.05 | 0.92 | |||
Obstructive TAPVC | 0.50 | 0.14–2.60 | 0.51 | |||
Systemic venous return | ||||||
Azygos continuation | 1.18 | 0.41–3.41 | 0.75 | |||
Bilateral SVC | 0.86 | 0.31–2.35 | 0.76 | |||
AVV regurgitation | ||||||
Greater than mild AVVR | 3.06 | 1.11–8.48 | 0.03 | 3.57 | 1.27–10.0 | 0.02 |
. | Univariable model . | Multivariable model . | ||||
---|---|---|---|---|---|---|
. | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
Morphology | ||||||
Right isomerism | 0.35 | 0.39–5.09 | 0.59 | |||
Common AVV | 0.46 | 0.17–1.24 | 0.13 | |||
Dextorcardia | 0.49 | 0.17–1.42 | 0.19 | |||
Dominant right ventricle | 1.41 | 0.41–5.12 | 0.59 | |||
Pulmonary flow | ||||||
Restrictive | 2.81 | 0.90–8.74 | 0.08 | 3.23 | 1.02–10.2 | 0.05 |
Balanced | 0.03 | 0.01–6.19 | 0.20 | |||
Excessive | 0.89 | 0.29–2.75 | 0.83 | |||
Pulmonary venous return | ||||||
TAPVC | 1.55 | 0.56–4.26 | 0.40 | |||
Extracardiac TAPVC | 0.56 | 0.36–3.05 | 0.92 | |||
Obstructive TAPVC | 0.50 | 0.14–2.60 | 0.51 | |||
Systemic venous return | ||||||
Azygos continuation | 1.18 | 0.41–3.41 | 0.75 | |||
Bilateral SVC | 0.86 | 0.31–2.35 | 0.76 | |||
AVV regurgitation | ||||||
Greater than mild AVVR | 3.06 | 1.11–8.48 | 0.03 | 3.57 | 1.27–10.0 | 0.02 |
AVV: atrioventricular valve; AVVR: atrioventricular valve regurgitation; HR: hazard ratio; SVC: superior vena cava; TAPVC: total anomalous pulmonary venous connection.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.